Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This creates a situation in which patients with certain comorbidities have access, while others with similar weight-related risks do not
GLP-1 medications are not inherently lifelong treatments, but the duration of therapy varies considerably based on why you're taking them, your response to treatment, and your overall health goals
CNS-targeted obesity (non-incretin) : Tradipitant (NK1R antagonist, Vanda, approved Dec 2025) and CNS delivery platform deals (Ophidion/Neuronasal, Dec 2025) point to a sparse but emerging non-incretin route
Protocol Health serves patients across Westchester and the NY/NJ/CT region both in Scarsdale and via telehealth
US$ 25.60
US$ 22.51
US$ 21.41
US$ 21.98
US$ 23.38
US$ 23.69
US$ 26.18
US$ 25.71
US$ 25.68
US$ 20.65
US$ 27.20
US$ 21.48
US$ 27.55
US$ 24.84
US$ 28.63
US$ 21.06
